Gene: PEX14
Official Full Name: peroxisomal biogenesis factor 14provided by HGNC
Gene Summary: This gene encodes an essential component of the peroxisomal import machinery. The protein is integrated into peroxisome membranes with its C-terminus exposed to the cytosol, and interacts with the cytosolic receptor for proteins containing a PTS1 peroxisomal targeting signal. The protein also functions as a transcriptional corepressor and interacts with a histone deacetylase. A mutation in this gene results in one form of Zellweger syndrome. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03192 | PEX14 Knockout cell line (HeLa) | Human | PEX14 | 1:3~1:6 | Negative | Online Inquiry |
KO03193 | PEX14 Knockout cell line (HCT 116) | Human | PEX14 | 1:2~1:4 | Negative | Online Inquiry |
KO03194 | PEX14 Knockout cell line (HEK293) | Human | PEX14 | 1:3~1:6 | Negative | Online Inquiry |
KO03195 | PEX14 Knockout cell line (A549) | Human | PEX14 | 1:3~1:4 | Negative | Online Inquiry |
PEX14 Gene Knockout Cell Lines are specifically engineered cellular models designed to study the role of the PEX14 gene, which encodes a protein critical for peroxisome biogenesis and function. These cell lines exhibit a targeted knockdown of the PEX14 gene, facilitating comprehensive investigations into cellular processes related to peroxisome metabolic pathways, including β-oxidation of fatty acids and reactive oxygen species detoxification.
The primary function of the PEX14 gene product is to mediate the docking of peroxisomal matrix proteins within the peroxisome, thereby ensuring proper organelle formation and function. By utilizing these knockout cell lines, researchers can elucidate the molecular mechanisms behind various peroxisomal disorders such as Zellweger spectrum disorders, characterized by the impaired synthesis and function of peroxisomes. The deletion of the PEX14 gene allows for in-depth analyses of the consequential cellular phenotypes, enabling the assessment of therapeutic strategies aimed at mitigating the effects of these genetic disorders.
In research settings, these cell lines are invaluable tools for investigating disease mechanisms, drug targeting, and metabolic regulation, potentially leading to the development of novel therapeutic approaches. Clinicians may also find this product beneficial for validating targeted treatments or enhancing diagnostic capabilities related to peroxisomal disorders.
Compared to alternative models, the PEX14 Gene Knockout Cell Lines present unique advantages, including higher specificity in genetic targeting and a stable genetic background, which minimizes variability in experimental outcomes. These attributes ensure reproducibility and reliability—factors crucial for robust scientific inquiry.
Researchers and clinicians alike can leverage the insights gained from these cell lines to advance their understanding of metabolic diseases, paving the way for innovative therapeutic interventions. Our company specializes in providing cutting-edge genetic tools that empower the scientific community, underscoring our commitment to advancing research and clinical practices in the field of genetics and cell biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.